VCU’s Rob Winn reflects on a year of COVID, racial reckoning, and being the sole Black director of an NCI-designated cancer center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Being Black and running an NCI-designated cancer center at a time of a worldwide pandemic, an ugly election, and a racial reckoning in a Southern town puts you in a position to make profound observations.

“Would I have chosen a different path or a different year to be a cancer center director? There are days where I think it would have been much easier,” said Robert Winn, director of VCU Massey Cancer Center.

For the next couple of weeks, until March 1, when Adekunle “Kunle” Odunsi becomes director of the University of Chicago Comprehensive Cancer Center, Winn will remain the only Black director of an NCI-designated cancer center. (With Odunsi’s appointment, the number of Black cancer center directors doubles.)

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.
Paul Goldberg
Editor & Publisher

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login